Summary
Caelum Biosciences Inc
Founded in 2019
Description
A clinical stage biotechnology company developing treatments for rare and life-threatening conditions.
Strengths
- Revenue growth is more steady than the industry average
- Since Caelum Biosciences Inc was founded, the company has grown faster than the industry average
Weaknesses
- Caelum Biosciences Inc has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
Annual Revenue
Caelum Biosciences Inc's annual revenue
$4253000
Based on Kona Equity data
-
Revenue per employee
$283533
-
Variance of revenue growth
0.01
-
Annual revenue growth since founding
$850600
-
Revenue growth rate from first known quarter to current
13.3%
Employee Count
15 employees
-
Employee growth rate from first known quarter to current
15.0%
Executives
Eileen Daniel
Senior VP, Development Operations
e**@caelumbio.comJessica Raviwong
Director, Quality Assurance
j**@caelumbio.comMichael Kahsai
Senior Vice President
m**@caelumbio.comSusan Sobolov
Chief Operating Officer
s**@caelumbio.comDaniel Brady
Head of Regulatory Affairs
d**@caelumbio.comJanet Jobes
Senior Director, Clinical Operations
j**@caelumbio.comJohn Glazer
Head of Corporate Development
j**@caelumbio.comJohn Silowsky
Executive Director, Clinical Operations
j**@caelumbio.comPreeti Kapoor
Pharmacovigilance Consultant
p**@caelumbio.comRoxanne Scott
Pv Operations Advisor & Consultant
r**@caelumbio.comIndrajit Giri
Director, Quality Assurance
i**@caelumbio.comGayleen Eichensehr
Clinical Research Associate
g**@caelumbio.comMargaret Ziola
Global Medical Lead
m**@caelumbio.comRebecca Schiller
Cra
r**@caelumbio.comMaureen Merrifield
Regulatory Affairs
m**@caelumbio.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
TRACON Pharmaceuticals
traconpharma.com- Founded in 2004
- Location: San Diego, CA
- Annual Revenue: $346.0K
- Employees: 19
- TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. They utilize a cost-efficient, contract research organization (CRO) independent product development platform to partner ...
ArQule , Inc.
arqule.com- Founded in 1993
- Location: Burlington, MA
- Annual Revenue: $2.4M
- Employees: 34
- ArQule, Inc. is a clinical stage biotechnology company engaged in the research and development of cancer therapeutics. The Company is focused on developing small molecule drugs that target specific biological pathways implicated in various cancers and ...
Savara
savarapharma.com- Founded in 2007
- Location: Austin, TX
- Annual Revenue: $1.0K
- Employees: 22
- Savara Inc. is a clinical stage biopharmaceutical company focused on rare respiratory diseases. They develop NanoCluster formulation technology based pulmonary drug delivery solutions. Their lead product candidate, molgramostim nebulizer solution, is i...
Bionavigen
bionavigen.com- Founded in 2018
- Location: Gaithersburg, MD
- Annual Revenue: $917.0K
- Employees: 4
- Bionavigen is a biopharmaceutical navigation company specializing in consulting for the discovery, preclinical development, translational, and regulatory sciences as well as early development of new drugs through smart acquisition. Bionavigen offers re...
Epygenix Therapeutics Inc
epygenix.com- Founded in 2016
- Location: Paramus, NJ
- Annual Revenue: $4.3M
- Employees: 16
- Epygenix is a precision medicine-based biopharmaceutical company discovering and developing drugs that treat Dravet syndrome and other genetic epilepsies.
Actinium Pharmaceuticals
actiniumpharma.com- Founded in 2000
- Location: New York City, NY
- Annual Revenue: $1.5M
- Employees: 32
- Actinium Pharmaceuticals is a biotechnology company focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers.
Key Information
- Name: Caelum Biosciences Inc
- SIC: 283; 28
- NAICS: 3254; 32
See similar companies
-
By City Bordentown
-
By State NJ Small companies in NJ
-
Firmographic data G Score of 2 Founded in 2019 SIC: 283 SIC: 28 NAICS: 3254 NAICS: 32 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Caelum Biosciences Inc's headquarters are located at 1200 Florence Columbus Rd. Bordentown, NJ 08505.
Caelum Biosciences Inc's official website is caelumbio.com
Caelum Biosciences Inc's annual revenue is $4.3 M.
Caelum Biosciences Inc's SIC: 283; 28
Caelum Biosciences Inc's NAICS: 3254; 32.
Caelum Biosciences Inc has 15 employees
